Portal de Boas Práticas em Saúde da Mulher, da Criança e do Adolescente

Postagens

Bexiga Hiperativa: abordagem multidisciplinar

10 set 2026

A Síndrome da Bexiga Hiperativa (SBH) afeta negativamente a qualidade de vida das mulheres. Sua abordagem inicial pode ser feita na APS, por equipe multidisciplinar, reservando a necessidade de tratamento hospitalar apenas para os casos de falha no tratamento conservador.

Skip to PDF content

Referência citada:

  • Haylen BT, de Ridder D, Freeman RM, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Int Urogynecol J. 2010;21(1):5-26. doi:10.1007/s00192-009-0976-9
  • Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50(6):1306-1315. doi:10.1016/j.eururo.2006.09.019
  • Robinson D, Cardozo L. Managing overactive bladder. Climacteric. 2019 Jun;22(3):250-256. doi: 10.1080/13697137.2018.1552254. PMID: 31034265.
  • Teloken C, Caraver F, Weber FA, et al. Overactive bladder: prevalence and implications in Brazil. Eur Urol. 2006;49(6):1087-1092. doi:10.1016/j.eururo.2006.01.026
  • Vaughan CP, Brown CJ, Goode PS, Burgio KL, Allman RM, Johnson TM 2nd. The association of nocturia with incident falls in an elderly community-dwelling cohort. Int J Clin Pract. 2010;64(5):577-583. doi:10.1111/j.1742-1241.2009.02326.x
  • Peyronnet B, Mironska E, Chapple C, et al. A Comprehensive Review of Overactive Bladder Pathophysiology: On the Way to Tailored Treatment. Eur Urol. 2019;75(6):988-1000. doi:10.1016/j.eururo.2019.02.038
  • Funada S, Luo Y, Uozumi R, Watanabe N, Goto T, Negoro H, Ueno K, Ichioka K, Segawa T, Akechi T, Ogawa O, Akamatsu S, Kobayashi T, Furukawa TA. Multicomponent Intervention for Overactive Bladder in Women: A Randomized Clinical Trial. JAMA Netw Open. 2024 Mar 4;7(3):e241784. doi: 10.1001/jamanetworkopen.2024.1784. PMID: 38477920; PMCID: PMC10938174.
  • Peter Herbison, Joanne E McKenzie. Which anticholinergic is best for people with overactive bladders? A network meta-analysis. First published: 21 December 2018 https://doi.org/10.1002/nau.23893
  • Nambiar AK, Arlandis S, Bø K, Cobussen-Boekhorst H, Costantini E, de Heide M, Farag F, Groen J, Karavitakis M, Lapitan MC, Manso M, Arteaga SM, Riogh ANA, O’Connor E, Omar MI, Peyronnet B, Phé V, Sakalis VI, Sihra N, Tzelves L, van Poelgeest-Pomfret ML, van den Bos TWL, van der Vaart H, Harding CK. European Association of Urology Guidelines on the Diagnosis and Management of Female Non-neurogenic Lower Urinary Tract Symptoms. Part 1: Diagnostics, Overactive Bladder, Stress Urinary Incontinence, and Mixed Urinary Incontinence. Eur Urol. 2022 Jul;82(1):49-59. doi: 10.1016/j.eururo.2022.01.045. Epub 2022 Feb 23. PMID: 35216856.
  • Maman K, Aballea S, Nazir J, Desroziers K, Neine ME, Siddiqui E, Odeyemi I, Hakimi Z. Comparative efficacy and safety of medical treatments for the management of overactive bladder: a systematic literature review and mixed treatment comparison. Eur Urol. 2014 Apr;65(4):755-65. doi: 10.1016/j.eururo.2013.11.010. Epub 2013 Nov 18. PMID: 24275310.
  • Drake MJ, Chapple C, Esen AA, Athanasiou S, Cambronero J, Mitcheson D, Herschorn S, Saleem T, Huang M, Siddiqui E, Stölzel M, Herholdt C, MacDiarmid S; BESIDE study investigators. Efficacy and Safety of Mirabegron Add-on Therapy to Solifenacin in Incontinent Overactive Bladder Patients with an Inadequate Response to Initial 4-Week Solifenacin Monotherapy: A Randomised Double-blind Multicentre Phase 3B Study (BESIDE). Eur Urol. 2016 Jul;70(1):136-145. doi: 10.1016/j.eururo.2016.02.030. Epub 2016 Mar 8. PMID: 26965560.

 

Conteúdo Relacionado

 

Como citar

FUNDAÇÃO OSWALDO CRUZ. Instituto Nacional de Saúde da Mulher, da Criança e do Adolescente Fernandes Figueira. Portal de Boas Práticas em Saúde da Mulher, da Criança e do Adolescente. Postagens: Bexiga Hiperativa: abordagem multidisciplinar. Rio de Janeiro, 10 set. 2026. Disponível em: <https://portaldeboaspraticas.iff.fiocruz.br/atencao-mulher/bexiga-hiperativa-abordagem-multidisciplinar/>.

Tags: Mobilização pela Saúde das Mulheres no SUS